A relationship is considered to be significant if (1) the person receives $10 000 or more during any 12-month period, or 5% or more of the person s gross income; or (2) the person owns 5% or more of the voting stock or share of the entity, or owns $10 000 or more of the fair market value of the entity. A relationship is considered to be modest if it is less than significant under the preceding definition. *Modest. Significant. associated with cardiac device infections: Leiden Device Registry. Heart. 2009;95:715 720. 20. Sohail MR, Uslan DZ, Khan AH, Friedman PA, Hayes DL, Wilson WR, Steckelberg JM, Stoner SM, Baddour LM. Risk factor analysis of per- manent pacemaker infection. Clin Infect Dis. 2007;45:166 173. 21. Klug D, Balde M, Pavin D, Hidden-Lucet F, Clementy J, Sadoul N, Rey JL, Lande G, Lazarus A, Victor J, Barnay C, Grandbastien B, Kacet S; PEOPLE Study Group. Risk factors related to infections of implanted pacemakers and cardioverter-defibrillators: results of a large prospective study. Circulation. 2007;116:1349 1355. 22. Da Costa A, Kirkorian G, Cucherat M, Delahaye F, Chevalier P, Cerisier A, Isaaz K, Touboul P. Antibiotic prophylaxis for permanent pacemaker implantation: a meta-analysis. Circulation. 1998;97:1796 1801. 23. Trappe HJ, Pfitzner P, Klein H, Wenzlaff P. Infections after cardioverter-defibrillator implantation: observations in 335 patients over 10 years. Br Heart J. 1995;73:20 24. 24. Lai KK, Fontecchio SA. Infections associated with implantable cardio- verter defibrillators placed transvenously and via thoracotomies: epide- miology, infection control, and management. Clin Infect Dis. 1998;27: 265 269. 25. Al-Khatib SM, Lucas FL, Jollis JG, Malenka DJ, Wennberg DE. The relation between patients outcomes and the volume of cardioverter- defibrillator implantation procedures performed by physicians treating Medicare beneficiaries [published correction appears in J Am Coll Cardiol. 2005;46:1964]. J Am Coll Cardiol. 2005;46:1536 1540. 